These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 38702933)
61. Effects of electroacupuncture on mitophagy mediated by SIRT3/PINK1/Parkin pathway in Parkinson's disease mice. Zhang GJ; Wang Y; Li JL; Ma J; Wang YC Zhen Ci Yan Jiu; 2024 Mar; 49(3):221-230. PubMed ID: 38500318 [TBL] [Abstract][Full Text] [Related]
62. Seo MH; Yeo S Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502283 [TBL] [Abstract][Full Text] [Related]
63. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro. Rojanathammanee L; Murphy EJ; Combs CK J Neuroinflammation; 2011 May; 8():44. PubMed ID: 21554732 [TBL] [Abstract][Full Text] [Related]
64. High frequency electrical stimulation reduces α-synuclein levels and α-synuclein-mediated autophagy dysfunction. George J; Shafiq K; Kapadia M; Kalia LV; Kalia SK Sci Rep; 2024 Jul; 14(1):16091. PubMed ID: 38997273 [TBL] [Abstract][Full Text] [Related]
65. Different patterns of exosomal α-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder. Yan YQ; Pu JL; Zheng R; Fang Y; Gu LY; Guo T; Si XL; Zhou C; Chen Y; Liu Y; Guan XJ; Xu XJ; Yan YP; Yin XZ; Zhang MM; Tao ZH; Zhang BR Eur J Neurol; 2022 Dec; 29(12):3590-3599. PubMed ID: 36047985 [TBL] [Abstract][Full Text] [Related]
66. Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson's Disease. Han S; Lim S; Yeo S Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628462 [TBL] [Abstract][Full Text] [Related]
67. Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice. Mani S; Sekar S; Barathidasan R; Manivasagam T; Thenmozhi AJ; Sevanan M; Chidambaram SB; Essa MM; Guillemin GJ; Sakharkar MK Neurotox Res; 2018 Apr; 33(3):656-670. PubMed ID: 29427283 [TBL] [Abstract][Full Text] [Related]
68. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487 [TBL] [Abstract][Full Text] [Related]
69. Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition. Fan RZ; Guo M; Luo S; Cui M; Tieu K Acta Neuropathol Commun; 2019 Nov; 7(1):184. PubMed ID: 31744532 [TBL] [Abstract][Full Text] [Related]
70. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA. Geng Y; Long X; Zhang Y; Wang Y; You G; Guo W; Zhuang G; Zhang Y; Cheng X; Yuan Z; Zan J J Transl Med; 2023 Sep; 21(1):652. PubMed ID: 37737187 [TBL] [Abstract][Full Text] [Related]
71. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072 [TBL] [Abstract][Full Text] [Related]
72. Decrease in Han S; Seo MH; Lim S; Yeo S Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422 [TBL] [Abstract][Full Text] [Related]
73. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis. Liu L; Zhou T; Li T; Liang Z; Luo X Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840 [TBL] [Abstract][Full Text] [Related]
74. Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson's disease. Hwang DJ; Koo JH; Kwon KC; Choi DH; Shin SD; Jeong JH; Um HS; Cho JY J Physiol Sci; 2018 Sep; 68(5):707-716. PubMed ID: 29260454 [TBL] [Abstract][Full Text] [Related]
75. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015 [TBL] [Abstract][Full Text] [Related]
76. Molecular events underlying the cell-to-cell transmission of α-synuclein. Choi YR; Park SJ; Park SM FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736 [TBL] [Abstract][Full Text] [Related]
77. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575 [TBL] [Abstract][Full Text] [Related]
78. TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells. Wang MX; Cheng XY; Jin M; Cao YL; Yang YP; Wang JD; Li Q; Wang F; Hu LF; Liu CF Exp Neurol; 2015 Sep; 271():112-21. PubMed ID: 26001614 [TBL] [Abstract][Full Text] [Related]
79. Interplay Between V-ATPase G1 and Small EV-miRNAs Modulates ERK1/2 Activation in GBM Stem Cells and Nonneoplastic Milieu. Bertolini I; Storaci AM; Terrasi A; Cristofori AD; Locatelli M; Caroli M; Ferrero S; Altieri DC; Vaira V Mol Cancer Res; 2020 Nov; 18(11):1744-1754. PubMed ID: 32753475 [TBL] [Abstract][Full Text] [Related]
80. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]